Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1830-1832

  Koukourakis, Michael I ^a   Giatromanolaki, Alexandra ^b   Skarlatos, John ^c   Corti, Luigi ^d   Blandamura, Stella ^d   Piazza, Mario ^d   Gatter, Kevin C ^e   Harris, Adrian L ^e  

^a UNIVERSITY OF THESSALY   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c SAINT SAVVAS HOSPITAL   (Greece)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1A; HYPOXIA INDUCIBLE FACTOR 2A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG TARGETING; ESOPHAGUS CANCER; HUMAN; HYPOXIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REOXYGENATION; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL NUCLEUS; COMBINED MODALITY THERAPY; CYTOPLASM; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035266307     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
2. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis
3. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1a
4. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
5. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
6. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award lecture
7. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro
8. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy
9. Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145
10. Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases
11. The expression and distribution of the hypoxia inducible factors HIF-1a and HIF-2a in normal human tissues, cancers and tumor associated macrophages
12. Long term survival of patients with early oesophageal cancer treated with photodynamic therapy and radiotherapy
13. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy
14. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked
15. Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade
16. Photodynamic therapy: A mitochondrial inducer of apoptosis
17. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
18. The role of microvascular damage in photodynamic therapy: The effect on vessel constriction, permeability, and leukocyte adhesion
19. Depletion of tumor oxygenation during photodynamic therapy: Detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]
20. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
21. Loss of PTEN facilitates HIF-1-mediated gene expression
22. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells